Scholar Rock outlines 2026 apitegromab BLA resubmission and commercial launch following FDA progress [Seeking Alpha]
Scholar Rock Holding Corporation (SRRK)
Last scholar rock holding corporation earnings: 11/12 07:30 am
Check Earnings Report
Company Research
Source: Seeking Alpha
CEO David Hallal stated that "Scholar Rock is poised for a transformative year in 2026," emphasizing the company's focus on delivering the world's first muscle-targeted therapy to children and adults Quick Insights Regulatory risks include the FDA reinspection outcome at Catalent Indiana, timing of BLA resubmission, reliance on facility compliance, potential for additional safety data requests, and EMA approval uncertainty linked to U.S. manufacturing compliance. Scholar Rock reported $368 million in cash, secured a $550 million debt facility for flexibility, and is actively managing operating and noncash expenses to maintain a strong financial position ahead of anticipated launches. Management advanced redundancy with a second fill-finish facility, completed engineering runs, and plans a supplemental BLA to address supply reliability issues beyond its primary site. More Trending News
Show less
Read more
Impact Snapshot
Event Time:
SRRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRRK alerts
High impacting Scholar Rock Holding Corporation news events
Weekly update
A roundup of the hottest topics
SRRK
News
- Scholar Rock (SRRK) had its price target raised by Citigroup Inc. from $55.00 to $58.00. They now have a "buy" rating on the stock.MarketBeat
- Scholar Rock (SRRK) had its price target raised by BMO Capital Markets from $50.00 to $70.00. They now have an "outperform" rating on the stock.MarketBeat
- Scholar Rock (SRRK) had its price target raised by Piper Sandler from $51.00 to $58.00. They now have an "overweight" rating on the stock.MarketBeat
- Scholar Rock (SRRK) had its "overweight" rating reaffirmed by Barclays PLC.MarketBeat
- Scholar Rock (SRRK) was given a new $55.00 price target by Truist Financial Corporation.MarketBeat
SRRK
Earnings
- 3/3/26 - Miss
SRRK
Sec Filings
- 3/3/26 - Form 8-K/A
- 3/3/26 - Form S-8
- 3/3/26 - Form 10-K
- SRRK's page on the SEC website